Bellevue Group AG trimmed its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,286 shares of the biotechnology company’s stock after selling 4,466 shares during the […]
Scout Investments Inc. decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 261,483 shares of the biopharmaceutical company’s stock after selling 4,095 shares during the period. Scout Investments Inc. owned about 0.20% of Halozyme […]
Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) fell 1.8% on Tuesday . The company traded as low as $5.60 and last traded at $5.60. 463 shares were traded during trading, a decline of 94% from the average session volume of 7,761 shares. The stock had previously closed at $5.71. Pasithea Therapeutics Trading Down 1.6 […]
Epoch Investment Partners Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 250.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,163,033 shares of the biopharmaceutical company’s stock after buying an additional 831,199 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Halozyme Therapeutics were worth $42,986,000 […]
Crestline Management LP lifted its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 67,243 shares of the biopharmaceutical company’s stock after buying an additional 4,133 shares during the quarter. Crestline Management LP’s holdings […]